20 Jan 2026 | 5 Mins Read
Sun Pharma eyes Organic growth with Organon acquisition
Flipitmoney
Sun Pharmaceutical Industries is assessing the acquisition of US-based Organon, a women's health-focused pharmaceutical company with a growing biosimilars portfolio, in a potential $10 billion deal. This would be Sun Pharma's largest acquisition and strengthen its US market presence, complementing its existing US portfolio and innovation capabilities, including branded products and biosimilars.